<?xml version="1.0" encoding="UTF-8"?>
<notes id="n1">
 <title>Notes</title>
 <p>
  <bold>
   <italic>Disclaimer.</italic>
  </bold> The content of this publication and the opinions expressed reflect those of the individual authors solely and do not necessarily reflect the views or policies of the Department of Health and Human Services, the National Institutes of Health (NIH), the National Cancer Institute (NCI), or the Food and Drug Administration, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government.
 </p>
 <p>
  <bold>
   <italic>Financial support.</italic>
  </bold> This work was supported by the Intramural Research Program of the NIH, NCI, Division of Cancer Epidemiology and Genetics.
 </p>
 <p>
  <bold>
   <italic>Potential conflicts of interest.</italic>
  </bold> T. R. O., L. P.-O., and R. P. D. are coinventors on patents for the interferon-Î»4 protein that are held by the NCI. All other authors report no potential conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
 </p>
</notes>
